Episode 190: Covid in 2022, J.P. Morgan bows to pressure, & the year in review
We've come to our last episode of the year, and first, STAT’s Helen Branswell joins us to talk about Omicron, boosters, and the past and future of the Covid-19 pandemic. Then, we'll review the year that was in biotech, discuss the suddenly virtual J.P. Morgan Healthcare Conference, and look forward to 2022.